Showing results (321-330 of 778) with videos related to

Sort By:
Pageof 78
British Journal of Pharmacology|January 22, 2008
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazideH Xu, K M Williams, W S Liauw, et al.
British Journal of Clinical Pharmacology|August 14, 2008
Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infectionJuliana F Roos, Carl M J Kirkpatrick, Susan E Tett, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 23, 2011
Aging biology and novel targets for drug discoveryDavid G Le Couteur, Andrew J McLachlan, Ronald J Quinn, et al.
International Journal of Clinical Pharmacy|July 24, 2015
Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementationNicole Lowres, Ines Krass, Lis Neubeck, et al.
Clinical Pharmacokinetics|July 28, 2007
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinolRichard O Day, Garry G Graham, Mark Hicks, et al.
Australasian Journal on Ageing|September 7, 2012
Adherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's diseaseDavid G Le Couteur, Maxine Robinson, Ann Leverton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Effect of clofibrate on the chiral disposition of ibuprofen in ratsS Scheuerer, K M Williams, R Brugger, et al.
Plos One|February 23, 2018
Correction: Management of vertebral compression fracture in general practice: BEACH programRodrigo Z Megale, Allan Pollack, Helena Britt, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 1, 2009
Ethnic differences in drug metabolism and toxicity from chemotherapyViet Hong Phan, Melissa M Moore, Andrew J McLachlan, et al.
The Clinical Journal of Pain|November 19, 2009
Can predictors of response to NSAIDs be identified in patients with acute low back pain?Mark J Hancock, Christopher G Maher, Jane Latimer, et al.
Pageof 78